BETing on the Therapeutic Potential of Super Enhancers
By Ebru Erbay
Science Translational Medicine : 260ec184
Antagonism of the bromodomain and extraterminal domain (BET) family of epigenetic reader and transcription cofactors represents a therapeutic opportunity in atherosclerosis.
BETing on the Therapeutic Potential of Super Enhancers
By Ebru Erbay
Science Translational Medicine : 260ec184
Antagonism of the bromodomain and extraterminal domain (BET) family of epigenetic reader and transcription cofactors represents a therapeutic opportunity in atherosclerosis.